{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T12:29:13Z","timestamp":1694780953538},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1097\/ftd.0000000000000732","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T19:00:50Z","timestamp":1579892450000},"page":"169-171","source":"Crossref","is-referenced-by-count":1,"title":["Drug Exposure and Effects in Pregnancy and Lactation"],"prefix":"10.1097","volume":"42","author":[{"given":"Philip D.","family":"Walson","sequence":"first","affiliation":[{"name":"Georg-August-Universitat, Hannover, Niedersachsen Germany. E-mail:."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"51e1","DOI":"10.1016\/j.ajog.2011.02.029","article-title":"Medication use during pregnancy, with particular focus on prescription drugs: 1976\u20132008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/FTD.0000000000000667","article-title":"Monitoring perinatal exposure to cannabis and synthetic cannabinoids","volume":"42","author":"Carlier","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/FTD.0000000000000709","article-title":"Therapeutic drug monitoring in pregnant patients","volume":"42","author":"Johnson-Davis","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1089\/jwh.2011.3118","article-title":"Clinical research enrolling pregnant women: a workshop summary","volume":"20","author":"Foulkes","year":"2011","journal-title":"J Womens Health (Larchmt)."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/FTD.0000000000000692","article-title":"Excretion of antipsychotics into the amniotic fluid, umbilical cord blood, and breast milk: a systematic critical review and combined analysis","volume":"42","author":"Schoretsanitis","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/FTD.0000000000000693","article-title":"Monitoring prenatal exposure to buprenorphine and methadone","volume":"42","author":"Di Trana","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/FTD.0000000000000724","article-title":"Pregnancy alters CYP- and UGT-mediated metabolism of buprenorphine","volume":"42","author":"Zhang","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/FTD.0000000000000691","article-title":"Monitoring of thyroid malfunction and therapies in pregnancy and the postpartum period: a systematic updated critical review of the literature","volume":"42","author":"Bohnet","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/FTD.0000000000000747","article-title":"Drug exposure in newborns: effect of selected drugs prescribed to mothers during pregnancy and lactation","volume":"42","author":"Rentsch","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/FTD.0000000000000719","article-title":"Testing unconventional matrices to monitor for prenatal exposure to heroin, cocaine, amphetamines, synthetic cathinones, and synthetic opioids","volume":"42","author":"Carlier","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/FTD.0000000000000735","article-title":"Therapeutic drug monitoring of HIV antiretroviral drugs in pregnancy: a narrative review","volume":"42","author":"O'Kelly","year":"2020","journal-title":"Ther Drug Monit."},{"key":"R19-20230814","doi-asserted-by":"crossref","first-page":"690.e1","DOI":"10.1016\/j.ajog.2014.06.013","article-title":"Trends in pregnancy labeling and data quality for US-approved pharmaceuticals","volume":"211","author":"Mazer-Amirshahi","year":"2014","journal-title":"Am J Obstetrics Gynecol."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/cpt.676","article-title":"Evaluation of the safety of drugs and biological products used during lactation: workshop summary","volume":"101","author":"Wang","year":"2017","journal-title":"Clin Pharmacol Ther."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:37:11Z","timestamp":1692052631000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000732","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}